Mark S. Cragg

Tremona Road
Southampton, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 168 publications

ACE2 decoy Fc-fusions and bispecific killer engagers require Fc engagement for in vivo efficacy against SARS-CoV-2.

ACE2 decoy Fc-fusions and bispecific killer engagers require Fc engagement for in vivo efficacy against SARS-CoV-2.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: May 27, 2026

The autoantigen TRIM21 assembles proinflammatory immune complexes after lytic cell death.

The autoantigen TRIM21 assembles proinflammatory immune complexes after lytic cell death.

Journal: Science immunology

Published: April 17, 2026

Realizing the potential of agonistic antibody immunotherapy.

Realizing the potential of agonistic antibody immunotherapy.

Journal: Nature reviews. Drug discovery

Published: April 13, 2026

Tailored FcγR blockade enhances immune checkpoint therapy and overcomes resistance.

Tailored FcγR blockade enhances immune checkpoint therapy and overcomes resistance.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 30, 2026

Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Employ Distinct Modes of Action to Induce Antitumor Immunity.

Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Employ Distinct Modes of Action to Induce Antitumor Immunity.

Journal: Cancer research

Published: January 16, 2026

CD40L and IL-4 lymph node-associated signals protect B cells from rituximab-induced ADCC via KIR and NKG2A.

CD40L and IL-4 lymph node-associated signals protect B cells from rituximab-induced ADCC via KIR and NKG2A.

Journal: Clinical and experimental immunology

Published: November 07, 2025

Resistance of BRAFV600E-mutant melanoma to Vemurafenib: a senescence-induced swing from differentiation to blastulation followed by proliferation.

Resistance of BRAFV600E-mutant melanoma to Vemurafenib: a senescence-induced swing from differentiation to blastulation followed by proliferation.

Journal: Cancer letters

Published: September 14, 2025

Gas-phase unfolding assay rapidly predicts structure-function relationships in engineered antibodies with tuned flexibilities.

Gas-phase unfolding assay rapidly predicts structure-function relationships in engineered antibodies with tuned flexibilities.

Journal: Nature communications

Published: August 22, 2025

Antibody binding geometry and affinity control inhibitory hFcγRIIB receptor signaling.

Antibody binding geometry and affinity control inhibitory hFcγRIIB receptor signaling.

Journal: Immunity

Published: July 02, 2025

CD27 Agonist Antibodies Mediate Clinical Responses through Intratumoral Stimulation in B-cell Malignancies: Multicenter RiVa Trial.

CD27 Agonist Antibodies Mediate Clinical Responses through Intratumoral Stimulation in B-cell Malignancies: Multicenter RiVa Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 29, 2025

CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axis.

CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axis.

Journal: Immunotherapy advances

Published: April 25, 2025

Harnessing multivalency and FcγRIIB engagement to augment anti-CD27 immunotherapy.

Harnessing multivalency and FcγRIIB engagement to augment anti-CD27 immunotherapy.

Journal: Nature communications

Published: December 10, 2024

Showing 1-12 of 168

Last Updated: 09/26/2026